- Conditions
- Respiratory Distress Syndrome (Neonatal), Surfactant
- Interventions
- Surfactant Administration Through Laryngeal or Supraglottic Airway (SALSA), Continuous Positive Airway Pressure (CPAP)
- Procedure
- Lead sponsor
- Sharp HealthCare
- Other
- Eligibility
- 33 Weeks to 38 Weeks
- Enrollment
- 422 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2031
- U.S. locations
- 3
- States / cities
- Chula Vista, California • La Mesa, California • San Diego, California
Source: ClinicalTrials.gov public record
Updated May 18, 2026 · Synced May 21, 2026, 11:24 PM EDT